MMJ Group Holdings Ltd

MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that Canadian-based Harvest One Capital Corp. (CVE:WON.H) has launched a C$15 million private placement to finalise the acquisition of the Company's cannabis subsidiaries United Greeneries Holdings Ltd and Satipharm AG respectively.

MMJ PhytoTech Limited (ASX:MMJ) advises in accordance with Listing Rule 3.10A, that the following securities will be released from escrow on Monday, 23 January 2017.

MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that its Canadian-based subsidiary, United Greeneries Ltd ("UG") has commenced cannabis growing operations at its state-of-the-art Duncan Facility.

MMJ PhytoTech Limited (ASX:MMJ) is pleased to provide shareholders with this Q&A update from Managing Director Andreas Gedeon.

MMJ PhytoTech Limited (ASX:MMJ) is pleased to provide the below statement following the Canadian Federal Government's Final Report into Cannabis Legalization and Regulation. The Report has been based on the findings and recommendations submitted by the Health Canada instigated Task Force.

MMJ PhytoTech Ltd (ASX:MMJ) today confirms that it has signed a definitive agreement with Canadian-based Harvest One Capital Corp. (CVE:WON). The definitive agreement outlines the sale of 100% of issued and outstanding shares of United Greeneries Holdings Ltd and Satipharm AG to Harvest One.

MMJ PhytoTech Ltd (ASX:MMJ) is pleased to provide the company's AGM Presentation with the topic "Developing a World-Class Pure Play Cannabis Company".

MMJ PhytoTech Ltd (ASX:MMJ) is pleased to advise that its Canadian subsidiary, United Greeneries Ltd, has received an Import Permit from Health Canada and the Canadian Food Inspection Agency, allowing for the importation of 1kg of cannabis seeds. Importantly, this will enable UG to commence cultivation activities at the Duncan Facility in December.

MMJ PhytoTech Ltd (ASX:MMJ) is pleased to advise that Canadian-based Mackie Research Capital Corporation has been appointed as lead manager for the equity financing component of the Company's proposed TSX-V listing.

MMJ PhytoTech Limited (ASX:MMJ) wishes to advise that it is fully supportive of recent amendments to Australian Commonwealth legislation, legalising cannabis-based products for medicinal or research purposes as controlled drugs.